a public good project by the
Synthesis
Company
of California

© 2026

Tessi Kanavarioti | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

Tessi Kanavarioti

Seagen (United States)(US)

Research Areas

Nanoparticle-Based Drug Delivery, Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research

Most-Cited Works

→ Characterization of a CC49-Based Single-Chain Fragment−β-Lactamase Fusion Protein for Antibody-Directed Enzyme Prodrug Therapy (ADEPT)(2006)39 cited